期刊文献+

高敏肌钙蛋白检测及临床应用有待解决的问题 被引量:10

The problems in detection and clinical application of high-sensitivity cardiac troponin
原文传递
导出
摘要 肌钙蛋白是急性冠状动脉综合征重要生物标志物.尤其是近年来兴起的高敏肌钙蛋白在心肌梗死早期诊断和预后评估中起着重要作用.一些国家也发布指南推荐高敏肌钙蛋白的应用.但临床医生和实验室工作人员在使用中仍有许多问题.本文就高敏肌钙蛋白测定和临床应用中的问题,以及国际组织的建议包括统一使用高敏肌钙蛋白名称、单位、确立健康人群选择指南以确定正确的第99百分位值,加以介绍并提出看法. Troponin is an important biomarker of acute coronary syndrome. Especially high- sensitivity cardiac troponin in recent years played an important role for the early diagnosis and prognosis of myocardial infarction. Recommendations for the use of high-sensitivity cardiac troponin have been issued in some guidelines. But the clinical doctors and laboratory workers still have many problems in practice. Some problems in high-sensitivity cardiac troponin assay and the clinical application were introduced here. Suggestions were also put up from international organizations, including unified high-sensitivity cardiac troponin name, unit, establish healthy population, selection guidelines to identify the 99th percentile value.
作者 贾克刚
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第7期485-488,共4页 Chinese Journal of Laboratory Medicine
基金 天津市自然科学基金面上项目(12JCYBJC17400) 滨海新区医药卫生科技重点项目(2011BHKZ003)
关键词 肌钙蛋白 生物学标记 敏感性与特异性 心肌梗死 Troponin Biological markers Sensitivity and specificity Myocardial infarction
  • 相关文献

参考文献12

  • 1Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction[ J]. Am Heart J, 1987,113: 1333-1344.
  • 2Apple FS. A new season for cardiac troponin assays: it's time to keep a seoreeard[ J]. Clin Cbem,2009,55: 1303-1306.
  • 3Tehrani DM, Seto AH. Third universal definition of myocardial infarction : update, caveats, differential diagnoses [ J ]. Cleve Clin J Med, 2013,80 : 777 -786.
  • 4Thygesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction[J]. Eur Heart J,2012,33 : 2551-2567.
  • 5Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays[ J]. Clin Chem,2012,58: 54-61.
  • 6Hickman PE, Potter JM, Aroney C, et al. Cardiac troponin may be released by ischemia alone, without necrosis [ J ]. Clin Chim Acta, 2010,411 : 318-323.
  • 7Jaffe AS, Apple FS, Morrow DA, et al. Being rational about (im) precision : a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction[ J]. Clin Chem,201O ,56 : 941-943.
  • 8Sandoval Y,Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin[ J ]. Clin Chem,2014,60: 455-462.
  • 9Wu AH. Interpretation of high sensitivity cardiac troponin I results : reference to biological variability in patients who present to the emergency room with chest pain: case report series[J]. Clin Chim Acta,2009,401: 170-174.
  • 10Nordenskjsid AM, Ahlstr~m H,Eggers KM, et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease[J]. Clin Chem,2013,59 : 401-409.

同被引文献80

  • 1Furuhashi M, Saitoh S, Shimamoto K, et al. Fatty acid-binding protein 4(FABP4) :pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases[J]. Clin Med Insights Cardiol, 2015,8(Suppl 3) : 23-33.
  • 2Figiel L,kasprzak JD,Peruga J,et al. Heart type fatty acid bind- ing protein-a reliable marker of myocardial necrosis in a heteroge-neous group of patients with acute coronary syndrome without persistent ST elevation[J]. Kardiol Pol, 2008,66 (3) : 253-259.
  • 3Cavallini C,Verdecchia P,Savonitto S,et al. Prognostic value of i solated troponin I elevation after percntaneous coronary interven- tion[J]. Circ Cardiovase Intcrv, 2010,3 (15) : 431-435.
  • 4Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin Ⅰ assay[J]. Clin Chem,2010, 56(21) :254-261.
  • 5Verdoia M,Schaffer A,Pergolini P, et al. Homocysteine levels in- fluence platelet reactivity in coronary artery disease patients trea- ted with acetylsalicylic acid[J]. J Cardiovasc Pharmacol, 2014,34 (21) :357-361.
  • 6White HD,Thygesen K,Alpert JS,et al.Clinical implications of the Third Universal Definition of Myocardial Infarction[J].Heart,2014(100):424-432.
  • 7Pawlus J,Rusak M,Choeiej-Stypulkowska J,et al.Parameters of platelets activation and myeloperoxidase concentration as mal'kers of coronary disease[J].Pol Merkur Lekarski,2010(29):259-262.
  • 8Rudolph V,Goldmann BU,Bos C,et al.Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction[J].Cardiol,2011(153):267-271.
  • 9Maguire OC,Cunninngham SK.Ischaemia-modified albumin:factor Fiction[J].Ann Clin Biochem,2010(47):182-183.
  • 10Shen XL,Lin CJ,Han LL,et al.Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndmme[J].Int J Cardiol,2011(149):296-298.

引证文献10

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部